Bioprocessing

Can 10x Genomics Thrive in 2025 with New Products and Strategic Shift?
Management & Regulatory Can 10x Genomics Thrive in 2025 with New Products and Strategic Shift?

10x Genomics, under the leadership of co-founder and CEO Serge Saxonov, PhD, is making a strategic shift towards enhancing customer support and expanding its presence in the biopharma market. Following a prolific year of product launches in 2024, the company is now focusing on promoting its recent

Bio-Rad Introduces TrailBlazer Kits for Advanced Antibody Labeling
Biotech & Bioprocessing Bio-Rad Introduces TrailBlazer Kits for Advanced Antibody Labeling

In a significant development for the scientific community, Bio-Rad Laboratories, Inc., a front-runner in life science research and clinical diagnostics products, unveiled its innovative TrailBlazer™ Tag and TrailBlazer StarBright™ Dye Label Kits. These advanced kits offer a seamless method for res

Transformative Trends in Biopharma: Preparing for 2025 and Beyond
Management & Regulatory Transformative Trends in Biopharma: Preparing for 2025 and Beyond

The biopharma industry stands at a transformative juncture as it reflects on the achievements of the past year and anticipates the evolving client requirements that will shape 2025 and beyond. Key insights from Subodh Deshmukh, CEO of Aragen Bioscience, highlight the crucial areas of focus for

McMaster and Sartorius Launch Bioprocessing Automation Lab
Biotech & Bioprocessing McMaster and Sartorius Launch Bioprocessing Automation Lab

In a remarkable advancement for the field of biotechnology, McMaster University and Sartorius have inaugurated a state-of-the-art bioprocessing automation laboratory at the university’s Faculty of Engineering, setting a new standard for bioprocess modeling, simulation, and advanced control. This c

Is Sanofi's Framingham Facility Falling Short of FDA Standards?
Biotech & Bioprocessing Is Sanofi's Framingham Facility Falling Short of FDA Standards?

The US Food and Drug Administration (FDA) raised serious concerns about Sanofi's manufacturing facility in Framingham, Massachusetts, by issuing a Warning Letter for significant deviations from current Good Manufacturing Practice (cGMP) standards for drug substance production. This alarming

Thermo Fisher CEO Predicts Expansion and Growth Amid GLP-1 Demand Surge
Biotech & Bioprocessing Thermo Fisher CEO Predicts Expansion and Growth Amid GLP-1 Demand Surge

In an optimistic outlook at the 43rd JPM Conference in San Francisco, Thermo Fisher CEO Marc Casper underscored the firm's strategic adaptations and growth initiatives tailored to meet surging demand for GLP-1 diabetes and weight loss products. Thermo Fisher Scientific's extensive

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later